Aberrant tyrosinase expression in an atypical fibroxanthoma: A case report

被引:1
|
作者
Weiss, Amy [1 ]
Vanchinathan, Vijay [2 ]
Kwon, Eun J. [2 ,3 ]
机构
[1] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA
[2] Rutgers State Univ, Div Dermatol, New Jersey Med Sch, Newark, NJ USA
[3] Dermpath Diagnost New York, 100 Midland Ave, Port Chester, NY 10573 USA
关键词
atypical fibroxanthoma; immunohistochemistry; MART-1; melan-A; tyrosinase; DIAGNOSTIC UTILITY; CD10; P63; KERATIN; VARIANT; MARKER; TUMORS; CELLS;
D O I
10.1111/cup.12900
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Atypical fibroxanthoma (AFX) is a histologic mimicker of a variety of spindle cell neoplasms, and careful microscopic and immunohistochemical evaluation is critical in establishing the correct diagnosis. Here we report the histologic and immunohistochemical work up of a 1cm nodule involving the left dorsal hand of a 66-year-old patient. Light microscopy revealed fascicles of spindled and pleomorphic cells within the dermis showing increased mitotic activity occurring in the background of sun-damaged skin. There were numerous multinucleated cells with hyperchromatic nuclei and ample finely vacuolated or foamy cytoplasms. There was strong and diffuse CD10 and patchy CD68 expression among the spindled cells and multinucleated cells. The neoplastic cells did not show immunoreactivity against S100, p75-NGFR, HMB-45 or a panel of keratinocytic, vascular and smooth muscle markers. Tyrosinase and Melan-A were not expressed within the spindle cell component of this neoplasm; however, there was tyrosinase expression among numerous multinucleated giant cells. Melan-A expression was also observed among rare multinucleated giant cells. Tyrosinase expression has not previously been reported in AFX.
引用
收藏
页码:467 / 469
页数:3
相关论文
共 50 条
  • [1] ATYPICAL FIBROXANTHOMA IN PHARYNX - CASE REPORT
    BERSCHADSKY, M
    GIANETTI, CD
    DAVID, A
    LOVERME, SR
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1973, 52 (04) : 443 - 445
  • [2] Atypical Fibroxanthoma Within a Melanoma: A Case Report
    Bhatti, Dujanah S.
    Raj, Dharshanan Raj Sela
    Khan, Muhammad Adil A.
    Ahmad, Raheel
    Ul Ain, Nur
    Smith, Louise J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [3] ATYPICAL FIBROXANTHOMA OF THE CHEEK - A CASE-REPORT
    LOO, DS
    DEPIETRO, WP
    MOISA, II
    TAWFIK, B
    CUTIS, 1993, 51 (01): : 47 - 48
  • [4] Scalp atypical fibroxanthoma. Report of one case
    Jara, Natalia
    Sole Z, Sebastian
    REVISTA MEDICA DE CHILE, 2019, 147 (10) : 1346 - 1349
  • [5] Aberrant Melan-A expression in atypical fibroxanthoma and undifferentiated pleomorphic sarcoma of the skin
    Thum, Chee
    Hollowood, Kevin
    Birch, Jeremy
    Goodlad, John R.
    Brenn, Thomas
    JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (12) : 954 - 960
  • [6] Atypical fibroxanthoma with T-cytotoxic inflammatory infiltrate and aberrant expression of cytokeratin
    Suarez-Vilela, Dimas
    Miguel Izquierdo, Francisco
    Escobar-Stein, Juliana
    Ramon Mendez-Alvarez, Jose
    JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (11) : 930 - 932
  • [7] Melanoma mimicking atypical fibroxanthoma: Report of an unusual case
    Wang, Yanqing
    Guo, Ying
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (12) : 1493 - 1496
  • [8] Atypical fibroxanthoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology
    Aimola, V.
    Piras, V.
    Ferreli, C.
    Atzori, L.
    Pinna, A.
    Rongioletti, F.
    Faa, G.
    Pilloni, L.
    VIRCHOWS ARCHIV, 2018, 473 : S220 - S220
  • [9] Utility of Aberrant p53 Expression in the Differentiation of Atypical Fibroxanthoma From Atypical Fibrous Histiocytoma
    Toumi, Gisele
    Cloutier, Jeffrey
    Charville, Greg
    Brown, Ryanne
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 362 - 362
  • [10] Utility of Aberrant p53 Expression in the Differentiation of Atypical Fibroxanthoma From Atypical Fibrous Histiocytoma
    Toumi, Gisele
    Cloutier, Jeffrey
    Charville, Greg
    Brown, Ryanne
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 362 - 362